Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Wall Street rises as investors watch stimulus, pandemic and earnings

Published 07/27/2020, 06:47 AM
Updated 07/27/2020, 04:40 PM
© Reuters. A nearly empty trading floor is seen as preparations are made for the return to trading at the NYSE in New York

By Sinéad Carew

(Reuters) - Wall Street's main indexes closed higher on Monday as investors bet on some of the market's most high-profile stocks ahead of earnings reports while they weighed progress in U.S. government stimulus efforts against rising U.S. COVID-19 cases.

Apple Inc (O:AAPL), Amazon.com Inc (O:AMZN), Facebook Inc (O:FB) and Alphabet Inc (O:GOOGL), all due to report earnings this week, were among the top boosters of the S&P 500. The technology-heavy Nasdaq posted a 1.7% gain, outperforming the S&P and the Dow.

Netflix (O:NFLX) and Microsoft (O:MSFT) also gained, noted John Augustine, chief investment officer at Huntington National Bank in Columbus, Ohio, who said investors were buying stocks in the group, which fell in recent sessions.

"When all six of them are higher they'll take markets with them," said Augustine, adding that with the exception of Facebook the so-called FAANG plus M stocks due to report have "a low bar to step over to beat earnings estimates."

The Dow Jones Industrial Average (DJI) rose 114.88 points, or 0.43%, to 26,584.77, the S&P 500 (SPX) gained 23.78 points, or 0.74%, to 3,239.41 and the Nasdaq Composite (IXIC) added 173.09 points, or 1.67%, to 10,536.27.

The biggest gainers among the S&P's 11 major sectors were technology (SPLRCT), up 1.6%, and materials (SPLRCM), up 1.4%, followed by real estate <.SPLRCR>, up 1.1%. Financials (SPSY), down 1.3%, and utilities (SPLRCU), down 0.8%, were the only sectors to end the day lower while energy (SPNY) eked out a small gain of 0.2%.

U.S. Senate Republicans raced to complete details of a $1 trillion coronavirus aid proposal before enhanced unemployment benefits expire on Friday. The aid proposal, which could involve a reduction in emergency federal weekly unemployment benefits from $600 to $200, would then need to be negotiated with Democrats.

After the market closed, senate majority leader Mitch McConnell said the package would address health, schools and include direct payments to Americans of $1,200 each.

Some investors have worried whether the package would provide sufficient support for the economy. These concerns were reflected in gains in assets viewed as safe havens such as the big growth companies and gold , according to Kristina Hooper, Chief Global Market Strategist at Invesco in New York.

"Today's story is about concerns that the economic recovery will be slow and halting. That's from a combination of an inability to bend the virus curve and what is shaping up to be a small stimulus package that may not address all the needs being created by this terrible crisis," said Hooper.

Trillions of dollars in fiscal and monetary stimulus have been pivotal pushing the S&P 500 closer to its February record high. It ended Monday's session 4.3% below the record.

On Monday, as the world confronted the prospect of rising COVID-19 infections, countries in Asia and Europe imposed new restrictions.

In the United States, where infection rates have climbed since June, two baseball games were canceled due to the virus while President Donald Trump's national security adviser Robert O'Brien was the most senior official to test positive.

Investors kept their eye on earnings, with 189 S&P 500 companies scheduled to report results this week. About 80% of the 130 S&P 500 firms that have reported so far have beaten a low bar of earnings estimates, according to IBES Refinitiv data.

Few expected any major announcement at a two-day Federal Reserve meeting, but analysts said policymakers were likely to lay the groundwork for more action later this year.

Moderna Inc (O:MRNA) shares finished up 9% after U.S. and company officials said its COVID-19 vaccine may be ready for widespread use by year-end. The drugmaker announced it started a trial to demonstrate safety and effectiveness, which could be the final hurdle prior to regulatory approval.

Advancing issues outnumbered declining ones on the NYSE by a 1.66-to-1 ratio; on Nasdaq, a 1.47-to-1 ratio favored advancers.

The S&P 500 posted 19 new 52-week highs and no new lows; the Nasdaq Composite recorded 64 new highs and 27 new lows.

© Reuters. A nearly empty trading floor is seen as preparations are made for the return to trading at the NYSE in New York

On U.S. exchanges 9.69 billion shares changed hands compared with the 10.6 billion average for the last 20 sessions.

Latest comments

The shorts are givin money to the banks thanks to a pumped market. I just follow the madness and make money :)
Gotta love welfare for wall street.
Wall Street priced in a much larger stimulus months ago. If it passes with only 1 trillion markets will likely go down.
No. It’s already well known that the Republicans only want a 1 trillion dollar plan for well over a month now. Old news. If the market was going to go down from that it would have already
Tom I'm referring to the fact that markets rose on second stimulus 2 months ago or more.
Veremos até quando essa impressão, é o fim do Capitalismo !
Ja, du har helt ret...
Why doesn't the FED just use this money buy gold??...:D
$200 PUA stimulus signs for HOPIUM??? Ha!
Lmao
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.